# A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

> **NCT07533565** · PHASE4 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 78 (actual)

## Conditions studied

- Cirrhosis
- Asthma

## Interventions

- **DRUG:** Mirabegron 100 mg
- **DRUG:** Mirabegron 50mg
- **DRUG:** Mirabegron 50mg
- **DRUG:** mirabegron 25 mg
- **DRUG:** Montelukast 10 mg
- **DRUG:** montelukast (5mg QD)
- **DRUG:** montelukast 4 mg granule

## Key facts

- **NCT ID:** NCT07533565
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533565, "A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07533565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*